Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Acceptability of a Digital Therapeutic for Adolescent Depressive Symptoms in Cardiology and Gastroenterology

NCT05461599 is registered in ClinicalTrials.gov with Limbix Health, Inc. as lead sponsor.

NCT NCT05461599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05461599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Acceptability of a Digital Therapeutic for Adolescent Depressive Symptoms in Cardiology and Gastroenterology
Lead sponsor
Limbix Health, Inc.
Phase
Not applicable
Overall status
Terminated
Start date
August 25, 2022
Completion date
May 16, 2023
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adolescent - emotional problem, adolescent behavior, cardiology, depression, depressive disorder, depressive episode, depressive symptoms, gastrointestinal diseases, major depressive disorder